Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Adrenal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05660889
What this trial is testing

Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Erasmus Medical Center 25
Not applicableNot Yet RecruitingNCT07812779
What this trial is testing

Thyroid Health Outcomes Registry for Surgery

Who this might be right for
Thyroid DiseasesThyroid NeoplasmsThyroid Cancer+9 more
Pirogov Russian National Research Medical University 3,000
Testing effectiveness (Phase 2)UnknownNCT04318730
What this trial is testing

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
West China Hospital 21
Not applicableUnknownNCT05763524
What this trial is testing

European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 90
Testing effectiveness (Phase 2)WithdrawnNCT00469469
What this trial is testing

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00002921
What this trial is testing

S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery

Who this might be right for
Adrenocortical Carcinoma
SWOG Cancer Research Network 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Large-scale testing (Phase 3)UnknownNCT00002659
What this trial is testing

Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Matrix Pharmaceutical 120
Early research (Phase 1)Looking for participantsNCT07189403
What this trial is testing

DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Advanced or Metastatic Adrenocortical CarcinomaMetastatic Castration-resistant Prostate Cancer
Daiichi Sankyo 40
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Early research (Phase 1)Looking for participantsNCT06041516
What this trial is testing

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Neuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)UnknownNCT00786110
What this trial is testing

Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients

Who this might be right for
Adrenocortical Carcinoma
University of Turin, Italy 30
Not applicableLooking for participantsNCT06141369
What this trial is testing

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Who this might be right for
Adrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine 21
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Not applicableStudy completedNCT06068101
What this trial is testing

Clinical and Genetic Investigation of the Association Between Primary Aldosteronism and Thyroid Cancer

Who this might be right for
Thyroid Cancer, PapillaryPrimary Aldosteronism
Instituto do Cancer do Estado de São Paulo 274
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT04187404
What this trial is testing

A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
Adrenocortical CarcinomaPheochromocytomaParaganglioma
Enterome 70
Testing effectiveness (Phase 2)UnknownNCT03257891
What this trial is testing

Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines

Who this might be right for
Adrenocortical Carcinoma
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 25
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT07392580
What this trial is testing

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

Who this might be right for
Laryngeal Squamous Cell Carcinoma
University of Miami 20
Next Page